Last Updated : August 28, 2013
Details
FilesGeneric Name:
Teriflunomide
Project Status:
Complete
Therapeutic Area:
Multiple sclerosis, relapsing-remitting
Manufacturer:
Genzyme Canada, a Division of Sanofi Aventis Canada Inc.
Call for patient/clinician input open:
Brand Name:
Aubagio
Project Line:
Reimbursement Review
Project Number:
SR0350-000
Call for patient/clinician input closed:
NOC Status at Filing:
Pre NOC
Performance Metric:
N/A — Predated performance metrics
Submission Type:
Initial
Indications:
Multiple Sclerosis, relapsing
Recommendation Type:
Do not list at the submitted price
Final Recommendation:
Files
Last Updated : August 28, 2013